R J Chenery

809 total citations
14 papers, 681 citations indexed

About

R J Chenery is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, R J Chenery has authored 14 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in R J Chenery's work include Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (3 papers) and Pharmacological Effects of Natural Compounds (3 papers). R J Chenery is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (3 papers) and Pharmacological Effects of Natural Compounds (3 papers). R J Chenery collaborates with scholars based in United States, United Kingdom and Canada. R J Chenery's co-authors include S. E. Clarke, J. C. Bloomer, Sandra Baldwin, Graeme Smith, Andrew W. Harrell, J. Brian Houston, Kathleen Hayes, B Brennan, Harriet G. Oldham and Robert F. Kirby and has published in prestigious journals such as British Journal of Clinical Pharmacology, Drug Metabolism and Disposition and Xenobiotica.

In The Last Decade

R J Chenery

14 papers receiving 642 citations

Peers

Countries citing papers authored by R J Chenery

Since Specialization

Citations

This map shows the geographic impact of R J Chenery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R J Chenery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R J Chenery more than expected).

Fields of papers citing papers by R J Chenery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R J Chenery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R J Chenery. The network helps show where R J Chenery may publish in the future.

Co-authorship network of co-authors of R J Chenery

This figure shows the co-authorship network connecting the top 25 collaborators of R J Chenery. A scholar is included among the top collaborators of R J Chenery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R J Chenery. R J Chenery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	In vitro identification of the P450 enzymes responsible for the metabolism of ropinirole. 1997 ·PubMed ·J. C. Bloomer, S. E. Clarke, R J Chenery	33
2	Determination of P4501A2 activity in human liver microsomes using [3-¹⁴C-methyl]caffeine 1995 ·Xenobiotica ·J. C. Bloomer, S. E. Clarke, R J Chenery	17
3	Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9 1995 ·Xenobiotica ·Sandra Baldwin, J. C. Bloomer, Graeme Smith, (unknown), S. E. Clarke, R J Chenery	269
4	In vivo disposition of caffeine predicted from hepatic microsomal and hepatocyte data. 1995 ·Drug Metabolism and Disposition ·Kathleen Hayes, B Brennan, R J Chenery, J. Brian Houston	51
5	Role of aldehyde oxidase in the in vitro conversion of famciclovir to penciclovir in human liver. 1995 ·Drug Metabolism and Disposition ·S. E. Clarke, Andrew W. Harrell, R J Chenery	75
6	Characterization of the inhibition of P4501A2 by furafylline 1994 ·Xenobiotica ·S. E. Clarke, (unknown), R J Chenery	66
7	Use of rat and human in vitro systems to assess the effectiveness and enzymology of deoxyguanine analogs as prodrugs of an antiviral agent. 1994 ·Drug Metabolism and Disposition ·Andrew W. Harrell, (unknown), (unknown), S. E. Clarke, R J Chenery	2
8	Use of rat and human in vitro systems to assess the effectiveness and enzymology of deoxy-guanine analogues as prodrugs of an antiviral agent. 1994 ·Drug Metabolism and Disposition ·Andrew W. Harrell, (unknown), (unknown), S. E. Clarke, R J Chenery	10
9	Characterisation of the cytochrome P450 enzymes involved in the in vitro metabolism of granisetron. 1994 ·British Journal of Clinical Pharmacology ·(unknown), (unknown), (unknown), (unknown), S. E. Clarke, R J Chenery	75
10	Evidence that famciclovir (BRL 42810) and its associated metabolites do not inhibit the 6 beta-hydroxylation of testosterone in human liver microsomes. 1993 ·Drug Metabolism and Disposition ·Andrew W. Harrell, (unknown), Michael Pennick, Stephen E. Clarke, R J Chenery	16
11	Metabolism of temelastine (SK&F 93944) in hepatocytes from rat, dog, cynomolgus monkey and man. 1990 ·Drug Metabolism and Disposition ·Harriet G. Oldham, (unknown), (unknown), Timothy J. Blake, Iain G. Beattie, Peter J. Cox, R J Chenery	3
12	The disposition of 2-cyano-1-methyl 3-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydro-pyridazin-3-yl)phenyl)guanidine in animals. 1990 ·Drug Metabolism and Disposition ·Douglas G. Walker, Michael G. Hutchison, (unknown), (unknown), (unknown), David J. Webb, N. Viney, M. A. Pue, R J Chenery, Paul Wood	1
13	Metabolism of temelastine (SK&F 93944) in hepatocytes from rat, dog, cynomolgus monkey and man. 1990 ·PubMed ·Harriet G. Oldham, (unknown), (unknown), Timothy J. Blake, Iain G. Beattie, Peter J. Cox, R J Chenery	11
14	Diazepam metabolism in cultured hepatocytes from rat, rabbit, dog, guinea pig, and man. 1987 ·Drug Metabolism and Disposition ·R J Chenery, Andrew D. Ayrton, Harriet G. Oldham, (unknown), (unknown), (unknown), Robert F. Kirby	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact